Skip to content

Paravertebral Block for Postoperative Analgesia in Children Undergoing Lateral Incision Cardiac Surgery With CBP

Effects of Paravertebral Block on Postoperative Analgesia in Children Undergoing Lateral Incision Cardiac Surgery With Cardiopulmonary Bypass: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06312904
Enrollment
100
Registered
2024-03-15
Start date
2024-03-11
Completion date
2024-08-14
Last updated
2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

Postoperative analgesia, paravertebral block, pediatric cardiac surgery, enhanced recovery after surgery

Brief summary

This study aims to compare the effect of paravertebral block and local infiltration anesthesia on postoperative analgesia in children undergoing lateral incision cardiac surgery with cardiopulmonary bypass. The researchers hope to investigate whether children who undergo paravertebral block experience less postoperative pain, have fewer postoperative complications, and recover more quickly.

Interventions

PROCEDUREparavertebral block

After cardiac surgery, the anesthesiologist will use 3mg/kg of 0.375% ropivacaine to conduct paravertebral block.

After cardiac surgery, the anesthesiologist will use 3mg/kg of 0.375% ropivacaine to conduct local infiltration anesthesia.

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

1. Children aged 6-14 years old; 2. Children who have atrial septal defect or ventricular septal defect scheduled for lateral incision cardiac surgery with cardiopulmonary bypass; 3. Inform consent signed by the parent or legal guardian.

Exclusion criteria

1. Patients who were intubated, on mechanical circulatory support, or with intravenous inotropes before surgery; 2. Emergency surgery or redo cardiac surgery; 3. Body weight more than 50kg; 4. Diagnosed as severe pulmonary hypertension; 5. Left ventricular ejection fraction less than 45% in most recent echocardiography before surgery; 6. Allergic to ropivacaine or other regular anesthetics, analgesics or other medications regularly used in the study; 7. Preoperative platelet counts less than 100\*109/L, coagulopathy or bleeding tendency ; 8. Preoperatively using antiplatelets or anticoagulants; 9. Diagnosed with scoliosis or other contraindications for PVB.

Design outcomes

Primary

MeasureTime frameDescription
opioid consumption during the first 24h after surgery24 hours postoperativelythe total amount of sufentanil and other opioids will be calculated as morphine equivalent dose (MED) divided by body weight

Secondary

MeasureTime frameDescription
FPS-R scale recorded at 6, 12, 18 and 24h postoperatively24 hours postoperativelyThe Faces Pain Scale-Revised (FPS-R) is a self-report measure of pain intensity developed for children. It was adapted from the Faces Pain Scale to make it possible to score the sensation of pain on the widely accepted 0-to-10 metric. The scale shows a close linear relationship with visual analog pain scales across the age range of 4-16 years. The bedside nurse will show the patients a picture of six faces, and score 0, 2, 4, 6, 8, and 10 from left to right. 0 equals no pain and 10 equals very much pain. They will ask the patient to choose a face that represents their current pain condition and record the pain score.
The rate of opioid treatment for remedial analgesia between groups24 hours postoperatively

Other

MeasureTime frameDescription
Length of postoperative mechanical ventilationthrough study completion, an average of 2 weeks
The rate of postoperative nausea and vomiting (PONV) during the 24h postoperativelythrough study completion, an average of 2 weeks
Length of ICU/hospital staythrough study completion, an average of 2 weeks
The incidence of respiratory depressionthrough study completion, an average of 2 weeksThe respiratory depression is defined as: with no obvious upper respiratory tract obstruction: SpO2 \< 90% and lasts for more than one minute, or respiratory rate \< 8 times/min, or SpO2 \< 94% and respiratory rate \< 10 times/min, or supplemental oxygen is needed to maintain SpO2 \> 94%.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026